Schizophrenia.com

Novel PDA10A Inhibitor for Schizophrenia in Development, Discussion With Maciej Wieczorek, PhD

everhopeful November 5, 2025, 1:12pm 1

3 Likes

Topic		Replies	Views	Activity
Discovery of pyrazolopyrimidine phosphodiesterase 10A inhibitors for the treatment of schizophrenia News	2	959	November 27, 2015
TAK-063, a PDE10A Inhibitor with Balanced Activation of Direct and Indirect Pathways, Provides Potent Antipsychotic-Like Effects in Multiple Paradigms News	9	1258	November 9, 2016
TAK-063, a novel PDE10A inhibitor with balanced activation of direct and indirect pathways, provides a unique opportunity for the treatment of schizophrenia News	3	566	January 11, 2018
A Proof-of-Concept Study Evaluating the Phosphodiesterase 10A Inhibitor PF-02545920 in the Adjunctive Treatment of Suboptimally Controlled Symptoms of Schizophrenia News	0	255	June 18, 2019
New Schizophrenia Medications In Development (2015) Medications	15	2776	September 23, 2015